The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex

Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the nervous system. The GABA signaling system in the brain is comprised of GABA synthesizing enzymes, transporters, GABAA and GABAB receptors (GABA(A)R and GABA(B)R). Alterations in the expression of these signaling components have been observed in several brain regions throughout aging and between sexes in various animal models. The hippocampus is the memory centre of the brain and is impaired in several age-related disorders. It is composed of two main regions: the Cornu Ammonis (CA1-4) and the Dentate Gyrus (DG), which are interconnected with the Entorhinal Cortex (ECx). The age- and sex-specific changes of GABA signaling components in these regions of the human brain have not been examined. This study is the first to determine the effect of age and sex on the expression of GABA signaling components-GABA(A)R alpha1,2,3,5, beta1-3, gamma2, GABA(B)R R1 and R2 subunits and the GABA synthesizing enzymes GAD 65 67-in the ECx, and the CA1 and DG regions of the human hippocampus using Western blotting. No significant differences were found in GABA(A)R alpha1,2,3,5, beta1-3, gamma2, GABA(B)R R1 and R2 subunit and GAD65 76 expression levels in the ECx, CA1 and DG regions between the younger and older age groups for both sexes. However, we observed a significant negative correlation between age and GABA(A)R alpha1subunit level in the CA1 region for females; significant negative correlation between age and GABA(A)R beta1, beta3 and gamma2 subunit expression in the DG region for males. In females a significant positive correlation was found between age and GABA(A)R gamma2 subunit expression in the ECx and GABA(B)R R2 subunit expression in the CA1 region. The results indicate that age and sex do not affect the expression of GAD 65 67. In conclusion, our results show age- and sex-related GABA(A B)R subunit alterations in the ECx and hippocampus that might significantly influence GABAergic neurotransmission and underlie disease susceptibility and progression.Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the nervous system. The GABA signaling system in the brain is comprised of GABA synthesizing enzymes, transporters, GABAA and GABAB receptors (GABA(A)R and GABA(B)R). Alterations in the expression of these signaling components have been observed in several brain regions throughout aging and between sexes in various animal models. The hippocampus is the memory centre of the brain and is impaired in several age-related disorders. It is composed of two main regions: the Cornu Ammonis (CA1-4) and the Dentate Gyrus (DG), which are interconnected with the Entorhinal Cortex (ECx). The age- and sex-specific changes of GABA signaling components in these regions of the human brain have not been examined. This study is the first to determine the effect of age and sex on the expression of GABA signaling components-GABA(A)R alpha1,2,3,5, beta1-3, gamma2, GABA(B)R R1 and R2 subunits and the GABA synthesizing enzymes GAD 65 67-in the ECx, and the CA1 and DG regions of the human hippocampus using Western blotting. No significant differences were found in GABA(A)R alpha1,2,3,5, beta1-3, gamma2, GABA(B)R R1 and R2 subunit and GAD65 76 expression levels in the ECx, CA1 and DG regions between the younger and older age groups for both sexes. However, we observed a significant negative correlation between age and GABA(A)R alpha1subunit level in the CA1 region for females; significant negative correlation between age and GABA(A)R beta1, beta3 and gamma2 subunit expression in the DG region for males. In females a significant positive correlation was found between age and GABA(A)R gamma2 subunit expression in the ECx and GABA(B)R R2 subunit expression in the CA1 region. The results indicate that age and sex do not affect the expression of GAD 65 67. In conclusion, our results show age- and sex-related GABA(A B)R subunit alterations in the ECx and hippocampus that might significantly influence GABAergic neurotransmission and underlie disease susceptibility and progression.